1. European Medicines Agency, Evaluation of Medicines for Human Use, CPMP. Note for Guidance on the Investigation of Bioavailability and Bioequivalence, London; 2001.
2. Center for Drug Evaluation and Research (CDER), Food and Drug Administration. Bioavailability and Bioequivalence Studies for Orally Administered Drug Products. General Considerations, Rockville, MD; 2003.
3. European Medicines Agency, Evaluation of Medicines for Human Use, CPMP. Guideline on the investigation of Bioequivalence, London; 2008.
4. Center for Drug Evaluation and Research (CDER), Food and Drug Administration. Guidance for Industry. Extended release oral dosage forms: development, evaluation, and application of in vitro/in vivo correlations, Rockville, MD; 1997.
5. Center for Drug Evaluation and Research (CDER), Food and Drug Administration. Waiver of in vivo bioavailability and bioequivalence studies for immediate-release solid oral dosage forms based on a biopharmaceutics classification system. Rockville, MD, 2000.